rs730880546
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000256.3(MYBPC3):c.1731G>A(p.Trp577Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000686 in 1,458,288 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000256.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYBPC3 | NM_000256.3 | c.1731G>A | p.Trp577Ter | stop_gained | 18/35 | ENST00000545968.6 | NP_000247.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.1731G>A | p.Trp577Ter | stop_gained | 18/35 | 5 | NM_000256.3 | ENSP00000442795 | P4 | |
MYBPC3 | ENST00000399249.6 | c.1731G>A | p.Trp577Ter | stop_gained | 17/34 | 5 | ENSP00000382193 | A2 | ||
MYBPC3 | ENST00000544791.1 | c.1731G>A | p.Trp577Ter | stop_gained, NMD_transcript_variant | 18/27 | 5 | ENSP00000444259 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000411 AC: 1AN: 243104Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 131944
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1458288Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 725046
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Cardiomyopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Jul 30, 2018 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 20, 2018 | The W577X variant (also referred to as W576X due to the use of alternate nomenclature) in the MYBPC3 gene has been reported previously in association with HCM (Santos et al., 2011). W577X has also been identified in two other individuals referred for cardiomyopathy testing at GeneDx. W577X is predicted to cause loss of normal protein function either by protein truncation or nonsense-mediated mRNA decay. Other nonsense variants in the MYBPC3 gene, including a different nucleotide substitution leading to a nonsense codon at the same amino acid residue (c.1730G>A, p.W577X), have been reported in Human Gene Mutation Database in association with HCM (Stenson et al., 2014). Lastly, the W577X variant has not been observed in large population cohorts (Lek et al., 2016). - |
Hypertrophic cardiomyopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 08, 2024 | This sequence change creates a premature translational stop signal (p.Trp577*) in the MYBPC3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYBPC3 are known to be pathogenic (PMID: 19574547). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 21425739). ClinVar contains an entry for this variant (Variation ID: 180943). For these reasons, this variant has been classified as Pathogenic. - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2022 | The p.W577* pathogenic mutation (also known as c.1731G>A), located in coding exon 18 of the MYBPC3 gene, results from a G to A substitution at nucleotide position 1731. This changes the amino acid from a tryptophan to a stop codon within coding exon 18. This pathogenic alteration has been reported in hypertrophic cardiomyopathy (HCM) cohorts (Santos S et al. Rev Port Cardiol, 2011 Jan;30:7-18; Brito D et al. Rev Port Cardiol, 2012 Sep;31:577-87). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at